NO20034785L - Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler - Google Patents

Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler

Info

Publication number
NO20034785L
NO20034785L NO20034785A NO20034785A NO20034785L NO 20034785 L NO20034785 L NO 20034785L NO 20034785 A NO20034785 A NO 20034785A NO 20034785 A NO20034785 A NO 20034785A NO 20034785 L NO20034785 L NO 20034785L
Authority
NO
Norway
Prior art keywords
pharma
anticancer agents
combinations based
degree surface
surface combinations
Prior art date
Application number
NO20034785A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034785D0 (no
Inventor
Bernard Bourrie
Pierre Casellas
Jean-Marie Derocq
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20034785D0 publication Critical patent/NO20034785D0/no
Publication of NO20034785L publication Critical patent/NO20034785L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20034785A 2001-04-27 2003-10-24 Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler NO20034785L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105843A FR2823975B1 (fr) 2001-04-27 2001-04-27 Nouvelle utilisation de pyridoindolone
PCT/FR2002/001450 WO2002087575A1 (fr) 2001-04-27 2002-04-26 Associations pharmaceutiques a base de derives de pyridoindolone et d'agents anticancereux

Publications (2)

Publication Number Publication Date
NO20034785D0 NO20034785D0 (no) 2003-10-24
NO20034785L true NO20034785L (no) 2003-12-23

Family

ID=8862882

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20034785A NO20034785L (no) 2001-04-27 2003-10-24 Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler
NO20034787A NO20034787L (no) 2001-04-27 2003-10-24 Anvendelse av pyridoindolonderivater var fremstilling av anticancer-medisiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20034787A NO20034787L (no) 2001-04-27 2003-10-24 Anvendelse av pyridoindolonderivater var fremstilling av anticancer-medisiner

Country Status (33)

Country Link
US (3) US6967203B2 (enExample)
EP (2) EP1385512B1 (enExample)
JP (2) JP2004531538A (enExample)
KR (1) KR100847413B1 (enExample)
CN (2) CN1505511A (enExample)
AR (1) AR034313A1 (enExample)
AT (2) ATE314070T1 (enExample)
BG (2) BG108260A (enExample)
BR (1) BR0209138A (enExample)
CA (2) CA2444334A1 (enExample)
CY (1) CY1105813T1 (enExample)
CZ (2) CZ295224B6 (enExample)
DE (2) DE60214533T2 (enExample)
DK (2) DK1385513T3 (enExample)
EA (1) EA005930B1 (enExample)
EE (2) EE200300466A (enExample)
ES (2) ES2271264T3 (enExample)
FR (1) FR2823975B1 (enExample)
HU (2) HUP0400745A2 (enExample)
IL (4) IL158266A0 (enExample)
IS (1) IS2441B (enExample)
MX (1) MXPA03009639A (enExample)
NO (2) NO20034785L (enExample)
NZ (1) NZ528671A (enExample)
PL (2) PL366910A1 (enExample)
PT (2) PT1385512E (enExample)
RS (2) RS50791B (enExample)
RU (1) RU2292888C9 (enExample)
SK (2) SK13242003A3 (enExample)
TW (1) TWI252104B (enExample)
UA (1) UA74876C2 (enExample)
WO (2) WO2002087575A1 (enExample)
ZA (1) ZA200307785B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) * 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
SU833972A1 (ru) 1979-10-26 1981-05-30 Институт Физико-Органической Химиии Углехимии Ah Украинской Ccp Имидазо(4,5-с)пиридиний иодиды вКАчЕСТВЕ пРОМЕжуТОчНыХ пРОдуКТОВ дл СиНТЕзА фуНгицидОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
US5035252A (en) * 1990-12-14 1991-07-30 Mondre Steven J Nicotine-containing dental floss
EP0581388A1 (en) * 1992-07-30 1994-02-02 Glaxo Group Limited Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists
JPH10501686A (ja) * 1994-04-13 1998-02-17 ザ ロックフェラー ユニヴァーシティ 神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
DE19624659A1 (de) * 1996-06-20 1998-01-08 Klinge Co Chem Pharm Fab Neue Pyridylalken- und Pyridylalkinsäureamide
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
CA2326319A1 (en) * 1998-04-02 1999-10-14 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) * 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US6958347B2 (en) 2002-12-18 2005-10-25 Pfizer Inc. Aminophenanthridinone and aminophenanthridine as NPY-5 antagonists
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CZ20032909A3 (en) 2004-06-16
YU83903A (sh) 2006-08-17
CA2444334A1 (fr) 2002-11-07
ATE338548T1 (de) 2006-09-15
BG108261A (bg) 2004-12-30
ES2271264T3 (es) 2007-04-16
WO2002087574A3 (fr) 2003-02-13
EE200300465A (et) 2003-12-15
US20050272760A1 (en) 2005-12-08
IL158266A (en) 2009-09-01
RU2292888C2 (ru) 2007-02-10
NZ528671A (en) 2004-06-25
US7160895B2 (en) 2007-01-09
EA005930B1 (ru) 2005-08-25
NO20034787L (no) 2003-12-23
DE60214533D1 (de) 2006-10-19
EA200301062A1 (ru) 2004-04-29
IL158312A (en) 2009-09-01
PT1385513E (pt) 2007-01-31
CZ295224B6 (cs) 2005-06-15
DE60208365T2 (de) 2006-09-07
YU83403A (sh) 2006-08-17
JP2004531538A (ja) 2004-10-14
AR034313A1 (es) 2004-02-18
SK13242003A3 (sk) 2004-03-02
HK1060066A1 (en) 2004-07-30
IS6984A (is) 2003-10-09
NO20034787D0 (no) 2003-10-24
MXPA03009639A (es) 2004-06-30
EP1385512A2 (fr) 2004-02-04
FR2823975B1 (fr) 2003-05-30
KR20040015138A (ko) 2004-02-18
DK1385512T3 (da) 2006-05-22
EP1385513B1 (fr) 2006-09-06
DE60214533T2 (de) 2007-06-21
RU2292888C9 (ru) 2007-06-20
CN1505511A (zh) 2004-06-16
DK1385513T3 (da) 2007-01-15
PL366910A1 (en) 2005-02-07
CA2443012C (fr) 2009-07-28
HK1059895A1 (en) 2004-07-23
CZ20032910A3 (en) 2004-07-14
NO20034785D0 (no) 2003-10-24
CZ299465B6 (cs) 2008-08-06
KR100847413B1 (ko) 2008-07-18
CA2443012A1 (en) 2002-11-07
UA74876C2 (en) 2006-02-15
HUP0400745A2 (hu) 2004-08-30
RS50791B (sr) 2010-08-31
EP1385512B1 (fr) 2005-12-28
DE60208365D1 (de) 2006-02-02
IL158266A0 (en) 2004-05-12
PT1385512E (pt) 2006-05-31
FR2823975A1 (fr) 2002-10-31
RU2003130376A (ru) 2005-04-10
PL366916A1 (en) 2005-02-07
CN1240382C (zh) 2006-02-08
EE200300466A (et) 2003-12-15
ZA200307785B (en) 2004-10-06
BR0209138A (pt) 2004-06-08
US6967203B2 (en) 2005-11-22
US7524857B2 (en) 2009-04-28
JP2004528343A (ja) 2004-09-16
IS2441B (is) 2008-11-15
ATE314070T1 (de) 2006-01-15
IL158312A0 (en) 2004-05-12
TWI252104B (en) 2006-04-01
WO2002087574A2 (fr) 2002-11-07
EP1385513A1 (fr) 2004-02-04
RS50790B (sr) 2010-08-31
SK13252003A3 (sk) 2004-03-02
WO2002087575A1 (fr) 2002-11-07
US20040122027A1 (en) 2004-06-24
CN1505510A (zh) 2004-06-16
US20040122036A1 (en) 2004-06-24
BG108260A (bg) 2004-12-30
CY1105813T1 (el) 2011-02-02
HUP0400744A2 (hu) 2004-06-28
ES2254683T3 (es) 2006-06-16

Similar Documents

Publication Publication Date Title
NO20041975D0 (no) Bicyklisk oksopyridin og oksopyrimidinderivater
DK1204649T3 (da) Arylmethylcarbonylaminothiazolderivater og deres anvendelse som antitumormidler
NO20035366D0 (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20032668D0 (no) Gyraseinhibitorer og anvendelser derav
DE50212857D1 (de) Fräs- und Bohrbearbeitungszentrum
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO20040469L (no) Heterocykliske forbindelser samt fremstilling og anvendelse derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
ATE314069T1 (de) Antineoplasische kombinationspräparate
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
ATE319451T1 (de) Tetrahydrochinolin-derivate
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
NO20025150L (no) 2-acylindolderivater og deres anvendelse som antitumormidler
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
NO20034022D0 (no) En kombinasjon omfattende combretastatin og anticancermidler
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
NO20034785L (no) Farmas degree ytiske kombinasjoner basert på pyridoindolonderivater og anticancer-midler
NO20024617L (no) Aryl- og heteroarylsulfonater
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
DE60202381D1 (de) Paroxetin-n-formyl-derivate
NO20025135D0 (no) Antihypertensive midler og anvendelse
DE60219418T8 (de) Silanylphenole und -naphthole
DK1453783T3 (da) Substituerede arylcycloalkaner og deres anvendelse som anticancermidler
DK1535622T3 (da) Melanomterapi
ITMI20011210A0 (it) Corticosteroidi-21-glicolati e 21-acilglicolati

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application